跳至主要内容
临床试验/IRCT20180407039219N1
IRCT20180407039219N1招募中3 期

Investigate the effect of alpha lipoic acid supplementation on serum level of LP-PLA2, it`s distribution between HDL and apo B containing lipoproteins and related oxidative stress and inflammatory markers in type 2 diabetic patients

Tehran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
All

入选标准

  • Willingness to cooperate
  • Age between 40-60 years old
  • Body mass index (BMI) between 18.5 to 29.9
  • At least 2 years of diagnosed type 2 diabetes
  • Controlled diabetes (HbA1C < 7%)

排除标准

  • Taking insulin
  • History of angina, myocardial infarction, and stroke, as well as other chronic diseases including liver disease, gastrointestinal disease, kidney disease, malignant disease, thyroid disease and other chronic and infectious diseases in the past year
  • Tobacco and alcohol consumption in the last three months
  • Changes in treatment protocols in the last three months
  • Taking any medicine other than metformin, glibenclamide, statin drugs, ACEI, ARB and doses less than 80 mg aspirin
  • Regular use of herbal Supplements containing antioxidants and omega-3 in the last three months (at least once a week)
  • Pregnancy and lactation

研究者

相似试验